188 related articles for article (PubMed ID: 12870229)
1. [Point mutation of TP53 suppressor gene in pre-neoplastic and neoplastic lesions of the stomach].
Araya JC; Roa JC; Villaseca MA; Roa I; Guzmán P; Alvarado C; Melo A
Rev Med Chil; 2003 Apr; 131(4):359-65. PubMed ID: 12870229
[TBL] [Abstract][Full Text] [Related]
2. [High frequency mutation of p53 gene in human gastric cancer and precancerous lesions].
Li Z; Lü Y
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):90-3. PubMed ID: 10920952
[TBL] [Abstract][Full Text] [Related]
3. [Microsatellite instability and loss of heterozygosity in neoplastic and preneoplastic gastric lesions].
Roa JC; Araya JC; Villaseca MA; Roa I; Correa P
Rev Med Chil; 2003 Nov; 131(11):1227-36. PubMed ID: 14743682
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
5. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type.
Ranzani GN; Luinetti O; Padovan LS; Calistri D; Renault B; Burrel M; Amadori D; Fiocca R; Solcia E
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):223-31. PubMed ID: 7606196
[TBL] [Abstract][Full Text] [Related]
6. Morphologic, histologic, and molecular similarities between adenocarcinomas arising in the gastric stump and the intact stomach.
Safatle-Ribeiro AV; Ribeiro Júnior U; Reynolds JC; Gama-Rodrigues JJ; Iriya K; Kim R; Bakker A; Swalsky PA; Pinotti HW; Finkelstein SD
Cancer; 1996 Dec; 78(11):2288-99. PubMed ID: 8940997
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach.
Semba S; Yokozaki H; Yamamoto S; Yasui W; Tahara E
Cancer; 1996 Apr; 77(8 Suppl):1620-7. PubMed ID: 8608553
[TBL] [Abstract][Full Text] [Related]
8. KRAS mutations predict progression of preneoplastic gastric lesions.
Gong C; Mera R; Bravo JC; Ruiz B; Diaz-Escamilla R; Fontham ET; Correa P; Hunt JD
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):167-71. PubMed ID: 10067815
[TBL] [Abstract][Full Text] [Related]
9. The RR genotype of codon 72 of p53 gene reduces the development of intestinal metaplasia.
Szoke D; Molnár B; Solymosi N; Sipos F; Galamb O; Gyorffy A; Tulassay Z
Dig Liver Dis; 2009 Mar; 41(3):179-84. PubMed ID: 18567547
[TBL] [Abstract][Full Text] [Related]
10. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.
Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI
Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123
[TBL] [Abstract][Full Text] [Related]
11. [Genetic changes in chronic gastritis: study of microsatellite instability and loss of heterozygosity].
Roa JC; Villaseca MA; Roa I; Araya JC
Rev Med Chil; 2003 Dec; 131(12):1365-74. PubMed ID: 15022398
[TBL] [Abstract][Full Text] [Related]
12. [Mutations of the p53 suppressor gene in gastric adenocarcinoma].
Aranda M; Náquira N; Karque R; Mendoza H; Sepúlveda C; Silva C
Rev Med Chil; 1998 May; 126(5):525-32. PubMed ID: 9731434
[TBL] [Abstract][Full Text] [Related]
13. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
[TBL] [Abstract][Full Text] [Related]
14. [Multiple gene alterations involved in the processor of human gastric carcinogenesis].
Lu Y; Li Z; Sun M
Zhonghua Yi Xue Za Zhi; 1995 Nov; 75(11):679-82, 710-1. PubMed ID: 8697090
[TBL] [Abstract][Full Text] [Related]
15. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP.
Gomyo Y; Osaki M; Kaibara N; Ito H
Int J Cancer; 1996 May; 66(5):594-9. PubMed ID: 8647618
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and genotypic events in gastric carcinogenesis.
Correa P; Shiao YH
Cancer Res; 1994 Apr; 54(7 Suppl):1941s-1943s. PubMed ID: 8137316
[TBL] [Abstract][Full Text] [Related]
17. The gastric mucosa in gastric cancer patients in a low-incidence area.
Genta RM; Pusztaszeri M
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1085-93. PubMed ID: 16957515
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
19. Gene alterations in intestinal metaplasia and gastric cancer.
Tahara E; Kuniyasu H; Yasui W; Yokozaki H
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S97-102. PubMed ID: 7735945
[TBL] [Abstract][Full Text] [Related]
20. Analysis of p53 abnormalities in endoscopic gastric biopsies.
Imatani A; Sasano H; Asaki S; Toyota T; Saito M; Masuda T; Nagura H
Anticancer Res; 1996; 16(4A):2049-56. PubMed ID: 8712741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
